Will Terns Pharmaceuticals' stock rise by at least 20% by December 31, 2024? | Binary | | | 4 months ago | |
Will TERN-601 receive FDA Fast Track designation by March 31, 2025? | Binary | | | 4 months ago | |
Will Terns Pharmaceuticals stock increase by 20% or more by the end of 2024? | Binary | | | 4 months ago | |
What will be the market share of TERN-601 compared to other weight-loss drugs by December 31, 2025? | Categorical | | | 4 months ago | |
Will Terns Pharmaceuticals complete Phase 2 clinical trial for TERN-601 by September 30, 2025? | Binary | | | 4 months ago | |
What will be Terns Pharmaceuticals' stock price at the end of 2024? | Categorical | | | 4 months ago | |
What will be the mean weight loss in Phase 2 clinical trial results for TERN-601? | Categorical | | | 4 months ago | |
When will TERN-601 Phase 2 trial results be announced? | Categorical | | | 4 months ago | |
Will TERN-601 show greater than 10% mean weight loss in Phase 2 trials? | Binary | | | 4 months ago | |
What will Terns Pharmaceuticals' stock price be at the end of 2024? | Categorical | | | 4 months ago | |
What will be TERN-601's mean weight loss in Phase 2 trials? | Categorical | | | 4 months ago | |
Will TERN-601 advance to Phase 2 clinical trials by the end of 2024? | Binary | | | 4 months ago | |
